Moffitt Presentations at SSO 2025
Note - all times are listed as EST
-
Thursday, March 27 - Sessions & Symposiums
13. Intratumorally delivered conventional type I dendritic cells in de novo stage 4 HER2 breast cancer patients lead to reduction in primary breast cancer and metastasis
Oral Abstract Session
Paige Aiello
8:34 - 8:40 a.m.
Room 122-12347. A cohort study of factors associated with survival and chronic aspirin use in colorectal cancer
Oral Abstract Session
Leah Hendrick
2:42 - 2:48 p.m.
Room 122-123Impact of Contemporary High-Impact Trials on Surgical Management of Patients with Sarcoma / Talk Title: The optimal duration of imatinib for patients with high-risk GIST
Symposium
Mihaela Druta, MD
2:43 - 3:08 p.m.
Ballroom AJohn Mullinax, MD
3:30 - 5:30 p.m.
Pan-Tumor HUB ZoneP43. Investigation of patient-derived organoid models as a system to study individualized therapy for colorectal cancer
Oral Abstract Session
Leah Hendrick
4:08 - 4:14 p.m.
Room 124-125P158. Collagenolysis by Enterococcus faecalis induces DDR1 signaling, proliferation and immune evasion in colorectal cancer
Oral Abstract Session
Richard Jacobson
9:30 - 9:36 p.m.
Room 124-125 -
Friday, March 28 - Sessions and Symposiums
73. Symposium: Uncommon Colorectal Malignancies & Challenging Clinical Situations
Oral Abstract Session
Rachel Voss, MD, MPH
8:00 - 8:09 a.m.
Ballroom ACross Disciplinary Patient Care in Surgical Oncology / Talk Title: Growing a Practice Together: Mentorship and Education in a Cross Disciplinary Practice
Symposium
Vernon Sondak, MD
8:15 - 8:30 p.m.
Ballroom D68. A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
Oral Abstract Session
Michelle Dugan
9:13 - 9:19 a.m.
Room 122-123Cross Disciplinary Patient Care in Surgical Oncology / Talk Title: Financial Sustainability in Utilizing APP’s within the Multidisciplinary Program: Program Location (Outpatient/Telehealth vs Inpatient/Facility Based) & Billing Incident to Provide vs Spit/Shared Billing
Symposium
David Johnson, PA-C
9:15 - 9:30 a.m.
Ballroom D105. Intra-tumoral mucolytic therapy for patients with unresectable pseudomyxoma peritonei: Results of an expanded access program
Oral Abstract Session
Michael Wach, MD
1:26 - 1:32 p.m.
Room 124-125P198. Evaluating the relationship between anemia, transfusion, and thromboembolic events in surgical geriatric cancer patients: a national study
Oral Abstract Session
Leah Hendrick
4:41 - 4:47 p.m.
Room 124-125 -
Saturday, March 29 - Symposium
Symposium Title: Newly Approved FDA Therapies for Melanoma / Talk Title: Percutaneous Liver Perfusion Future Directions, Unanswered Questions
Symposium
Jonathan Zager, MD
9:30 - 9:45 a.m.
Ballroom A